| Identification | Back Directory | [Name]
N2-[(2R)-4-[(1,1-DiMethylethoxy)aMino]-2-(2-naphthalenylMethyl)-1,4-dioxobutyl]-N5-[[[2,3-dihydro-2,2,4,6,7-pentaMethyl-5-benzofuranyl]sulfonyl]aMino]iMinoethyl-L-ornithine | [CAS]
1093740-20-5 | [Synonyms]
N2-[(2R)-4-[(1,1-DiMethylethoxy)aMino]-2-(2-naphthalenylMethyl)-1,4-dioxobutyl]-N5-[[[2,3-dihydro-2,2,4,6,7-pentaMethyl-5-benzofuranyl]sulfonyl]aMino]iMinoethyl-L-ornithine
L-Ornithine, N5-[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(2R)-4-[(1,1-dimethylethoxy)amino]-2-(2-naphthalenylmethyl)-1,4-dioxobutyl]-
(2S)-5-[[amino-[(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-yl)sulfonylamino]methylidene]amino]-2-[[(2R)-4-[(2-methylpropan-2-yl)oxyamino]-2-(naphthalen-2-ylmethyl)-4-oxobutanoyl]amino]pentanoic acid | [Molecular Formula]
C38H51N5O8S | [MDL Number]
MFCD31562323 | [MOL File]
1093740-20-5.mol | [Molecular Weight]
737.91 |
| Hazard Information | Back Directory | [Uses]
Intermediate in the synthesis of substrate-selective peptide hydroxamate inhibitor of insulin-degrading enzyme, N2-[(2R)-4-(Hydroxyamino)-2-(2-naphthalenylmethyl)-1,4-dioxobutyl]-L-arginyl-L-tryptophyl-L-α-glutamine (H828110). |
|
|